the current standard for liver preservation involves cooling of the organ on ice (0-4 °c). although it is successful for shorter durations, this method of preservation does not allow long-term storage of the liver. the gradual loss of hepatic viability during preservation puts pressure on organ sharing and allocation, may limit the use of suboptimal grafts and necessitates rushed transplantation to achieve desirable post-transplantation outcomes. In an attempt to improve and prolong liver viability during storage, alternative preservation methods are under investigation. For instance, ex vivo machine perfusion systems aim to sustain and even improve viability by supporting hepatic function at warm temperatures, rather than simply slowing down deterioration by cooling. Here we describe a novel subzero preservation technique that combines ex vivo machine perfusion with cryoprotectants to facilitate long-term supercooled preservation. the technique improves the preservation of rat livers to prolong storage times as much as threefold, which is validated by successful long-term recipient survival after orthotopic transplantation. this protocol describes how to load rat livers with cryoprotectants to prevent both intracellular and extracellular ice formation and to protect against hypothermic injury. cryoprotectants are loaded ex vivo using subnormothermic machine perfusion (snMp), after which livers can be cooled to −6 °c without freezing and kept viable for up to 96 h. cooling to a supercooled state is controlled, followed by 3 h of snMp recovery and orthotopic liver transplantation. it can certainly be envisioned that ex vivo machine perfusion will have a cooperative role with other preservation techniques.
IntroDuctIon
Liver preservation aims to minimize injury and to maintain the organ outside the body to provide the highest quality organ for transplantation. For decades, liver preservation has been limited to static cold storage (SCS) of the organ on ice. Under these conditions, the reduced temperature (0-4 °C) results in hypometabolism and a slower deterioration of organ function and structural integrity than at warm temperatures. SCS is facilitated by specialized organ preservation solutions that support a reduction in metabolic activity. Although SCS has enabled transplantation for many years, it is limited in both the duration of preservation and the number of livers that are of sufficiently high quality to endure additional injury sustained during SCS. On ice, the liver still suffers a relatively fast deterioration, as evidenced by a substantial loss of energy stores and viable cells 1 . As a result, livers are best transplanted within 12 h clinically 2 .
Demands to extend the preservation time and improve postpreservation organ quality led to the development of an alternative storage technique based on supercooling or subzero nonfreezing 3 . The additional reduction of liver metabolism at subzero temperatures further slows down the deterioration of the liver, thus preserving energy stores and cellular homeostasis 4, 5 . Improved preservation allows longer viable preservation times, and it may result in the expansion of the criteria for clinically transplantable donor livers by reducing additional injury to currently discarded grafts. We anticipate that supercooling will be applicable to biopreservation throughout both experimental biomedical and clinical fields, ranging from the preservation of isolated cells to the transplantation of solid organs and tissues.
Subzero preservation has been a desirable, yet elusive, feat for many years. The main impediment was the formation of ice in the tissue, which thus far has been insurmountably detrimental 6 . Despite numerous attempts to prevent or control ice crystal growth, substantial post-thaw function, let alone transplant survival has yet to be realized. Supercooling offers an alternative by avoiding ice formation altogether. By enabling subzero preservation, we have achieved a substantial improvement over current preservation times, extending viable preservation time threefold 3 .
Comparison of liver preservation techniques
Optimal preservation has been a major focus for as long as organ transplantation has been a reality. The first liver transplantions were performed by incorporating pump-driven perfusion of the organ in an attempt to maintain oxygenation of the liver 7 . The relatively high complexity of these machine perfusion modalities resulted in a quick replacement by simpler static hypothermic preservation with solutions such as the University of Wisconsin (UW) solution, which greatly improved the results of SCS 8, 9 . For many years, SCS has been the standard, providing very good outcomes. However, more recently, as a consequence of increasingly severe donor liver shortages, alternative storage techniques are being explored to improve the preservation of marginal grafts that yield inferior results when conventionally preserved 10 .
Ex vivo machine perfusion techniques are being developed over a range of different temperatures 11 . Hypothermic machine perfusion at ±4 °C has been used clinically, and the results have been promising, even after just an hour of perfusion 12, 13 . Alternatives, such as normothermic machine perfusion (37 °C) and SNMP (±21 °C), are also making a clinical translation following reports showing that human livers can be metabolically sustained at warm temperatures 14, 15 . Although increasing evidence supports machine perfusion as a superior preservation method, the complexity of sustained ex vivo organ metabolism may conceptually limit machine perfusion to shorter preservation periods. However, Supercooling preservation and transplantation of the rat liver it can certainly be envisioned that ex vivo machine perfusion will have a cooperative role with other preservation techniques.
Experimental design
The supercooling technique described here is based on three principles: supercooling of the organ, machine perfusion and cryoprotection. The liver is cooled to −6 °C and kept in an unfrozen state through the application of various cryoprotectants. As freezing can occur in both the intracellular liquid phase and the extracellular space, a cryoprotectant is needed to protect each. As amphibious species have showed remarkable freeze resistance based on glucose cryoprotection, a non-metabolizable form of glucose is loaded into the hepatic cells to achieve a similar protective effect. This 3-O-methyl glucose (3-OMG) is internalized by cellular glucose transporters, but its chemical variation prevents further metabolism, resulting in intracellular accumulation 16 . For the intravascular space, high-molecular-weight PEG is used. PEG is a known ice modulator, which directly inhibits ice crystallization and has added benefits to cellular membranes. The tandem application of 3-OMG and PEG allowed for 100% freeze-avoidance in rat livers stored for multiple days at −6 °C. Moreover, PEG was used to protect against hypothermic injury that is independent of ischemia, such as lipid peroxidation and cell membrane injury [17] [18] [19] . Machine perfusion is instrumental in completing this protocol. A SNMP protocol at 21 °C was used both before and after supercooling. This temperature was chosen to provide a temperature conducive to both loading of 3-OMG and functional testing. This SNMP system perfuses the liver with a nutrient-rich, oxygenated perfusion solution (perfusate) that has been shown to recover rat livers after both warm and cold ischemia 20, 21 . Before supercooling, the perfusate is supplemented with 3-OMG, and an hour of SNMP facilitates loading of the cryoprotectant. The SNMP system has been applied to the recovery of livers at the end of preservation, thus substantially improving post-transplantion survival 21 . Herein, 3 h of SNMP was performed at the end of supercooling, presenting a recovery period for the liver before orthotopic transplantation.
This proof-of-concept protocol shows that supercooling can improve the preservation of healthy livers that have not sustained (warm) ischemic injury. Conventional SCS serves as a control protocol for preservation experiments, and it involves an in situ flush of cold preservation solution, e.g., UW solution or histidinetryptophan-ketoglutarate solution (Box 1). Our experiments showed that all components of the supercooling protocol are essential for successful outcome. Omission of either of the cryoprotectants, pre-or post-supercooling SNMPs, or supercooling led to ineffective preservation of the liver. In addition, successful orthotopic rat liver transplantation begins and ends with proficient microsurgical procedures, the essentials of which are also outlined in this protocol.
Limitations and adaptations to this protocol
The supercooling technique is applied in a brain-dead donation model of healthy small animals. This offers the best organ condition because there is no warm ischemia. We have yet to test the robustness of supercooling in more ischemic liver models or models of diseased organs, such as fatty liver disease or grafts from older donors. Surgical adaptations incorporating a warm ischemic period can be applied to mimic cardiac death donation. Various cardiac death models exist, including pharmacological cardiac arrest 22 , phrenotomy 23, 24 , diaphragmatic incision 25 , exsanguination 26, 27 , ventilator withdrawal 28 , arterial clamping 29 and ex situ warm ischemia 30 . An important consideration is that rodents cool down rapidly after cardiac death, thus reducing the severity of warm ischemia. It is important to adequately control temperature during in situ warm ischemia to ensure a reproducible model. This supercooling protocol, in particular the temperature development, was optimized for small organs (±10 g). As temperature changes throughout the process are crucial, we anticipate that various adaptations will be required to scale this method to larger organs. It is our impression that homogeneous cooling and warming are key features of the protocol. The gradual changes in temperature that have been outlined here were optimized for small livers, and it is to be expected that human-sized livers (±1.5-2 kg) will require a more prolonged cooling and rewarming phase. We have recently translated the SNMP elements of the supercooling protocol to a human liver scale and demonstrated the feasibility of this human SNMP system in supporting human liver function 15 .
Box 1 | SCS control • tIMInG 1-4 d + follow-up period
SCS remains the clinical standard for liver preservation, and it is the most relevant control group for preservation studies. A short period of SCS can be used to verify the surgical technique, as well as to determine the maximum SCS preservation time. In our model, we found viable preservation after SCS to be limited to 24 h (see ANTICIPATED RESULTS section). Solubilize 50 g of PEG, molecular mass 35 kDa (PEG 35 kDa), in 1 liter (5% wt/vol). Divide the solution into 100-ml aliquots in 125-ml bottles, filtered through 0.22-µm bottle-top filters. ! cautIon Long-term storage of UW solution results in gradual oxidation of glutathione and must be avoided, or alternatively glutathione can be supplemented.  crItIcal Supercooling solution can be stored up to 90 d, but it must be refrigerated (4 °C). Recovery solution The recovery solution differs from the 3-OMG loading solution in the supplementation of 3-OMG and the concentration of insulin. To prepare the recovery solution, aseptically add 5 ml of 200 mM l-glutamine (0.292 mg/l), 4 ml of penicillin-streptomycin (5,000 U/ml), 5 mg of hydrocortisone, 5,000 U of sodium heparin and 1 U of insulin to a 500-ml bottle of phenol red-free Williams' medium E. The final osmolality of the solution should be 290-310 mOsm. Check the pH of the solution, and correct it to a pH of 7.35-7.45 using NaHCO 3 base or HCl acid. Filter the solution through 0.22-µm bottle-top filters to sterilize.  crItIcal l-Glutamine is not stable in solution, and insulin must be kept cold. Prepare the solution just before use and keep the solution on ice before priming the perfusion system. Warm saline Heat 100 ml of normal saline to 37 °C in a water bath before the liver procurement and transplantation. Warm saline is used to keep the tissues moist during the procedure, as well as to maintain body temperature. Use warm saline to irrigate the abdomen of the recipient before closing. EQUIPMENT SETUP SNMP system The SNMP system consists of a single circulation providing portal venous perfusion through the rat liver and passive outflow of the solution from two sides of the vena cava, into the organ chamber (Fig. 1 ). An outflow pump returns the perfusion solution to a reservoir bottle. The system can be opened, stopping recirculation by draining the outflow tubing into a waste container, rather than returning it to the reservoir.
An inflow pump drives the solution around various components of the system ending in the liver. Begin the setup by ensuring a clean and stable workplace, preferably a clean lab bench, table top or flow hood. Place a sterile drape on the surface. Attach various ring clamps for the oxygenator, bubble trap and organ chamber to the lab stand and install the components securely in the rings. The bubble trap should be placed at a level higher than the organ chamber. Next, measure lengths of size 16 tubing to run (i) between the perfusion solution reservoir and the oxygenator, through the pump head; and (ii) from the oxygenator to the bubble trap. Use a 15-cm section of membrane oxygenator tubing to run from the bubble trap to an 18-gauge catheter (inflow catheter), which can be connected through a 1/8-inch male-male Luer adapter. Ensure that the inflow and outflow of the bubble trap are connected to the correct side. Attach the pieces of tubing to the system components using 1/8-inch male-female Luer adapters. Suspend the inflow catheter over the organ chamber. Cut the section of the oxygenator tubing between the bubble trap and the inflow catheter 2 cm above the catheter and insert a small three-way connector. Attach a 20-cm length of tubing to the third connection running up, to serve as a hydrostatic manometer (Fig. 1d) . Fix the gas regulator to a tank of 95% O 2 /5% CO 2 gas. Run the tubing from the tank to the inflow of the oxygenator and confirm adequate movement of air from the oxygenator outflow tubing. ! cautIon Tanks must be tightly secured to prevent injury.  crItIcal Sterilize the components of the system before assembly. Supercooling device A controlled rate chiller is used with the supercooling device to control the temperature internally during the supercooling period, as well as to control the temperature of the machine perfusion system. A second antifreeze circuit of tubing runs from the supercooling device through the jacketed components of the system independent from the perfusion solution circuit (Fig. 1a, blue lines) . To set this up, run size 24 tubing from (i) the outflow port of the chiller to the organ chamber, (ii) from the organ chamber to the bubble trap, (iii) from the bubble trap to the oxygenator and (iv) from the oxygenator back to the inflow of the chiller. Fill the inner chamber of the supercooling device with antifreeze solution. Wrap long segments of antifreeze tubing in the tube insulator to further minimize temperature equilibration. Begin recirculation of the antifreeze solution through the system, by filling the tubing and component jackets. Remove air from the system. ! cautIon Antifreeze solutions can be toxic; always wear protective equipment and avoid contact of the antifreeze solution with skin and eyes.  crItIcal The order of flow is important, as minimal equilibration of the antifreeze temperature occurs with the atmosphere, while passing through the tubing. The order reflects the priority of cooling, which decreases with distance from the liver. Sterile surgical table In preparation for liver procurement and liver transplantation, a clean surgical table must be prepared. It is important to prepare the table with a clear presentation of instruments to maintain sterility and to facilitate a smooth procedure. Disinfect the surface with an alcohol spray, and cover the surgical field with sterile drapes. Position a heating pad and cover it with a sterile drape. Place sterile instruments in preferred locations. Cut sutures to size. Cut a 6-cm section of 28-gauge polyethylene tubing for cannulation of the bile duct and sterilize. Attach a 100% oxygen tank to the rodent anesthesia machine, and fill the machine with isoflurane. Vascular cuffs Cuffs, fashioned from catheters, sustantially shorten the vascular anastomosis time during transplantation 27 . Cut a 4-mm section off the catheter and secure one end in a mosquito clamp (Fig. 2a,b) . Make a hemicircumferential cut through in the middle of the section, and remove one side of the top half by making two cuts inward from the side joining with the hemicircumferential cut (Fig. 2c) . Remove and discard the loose quarter section. Use the cautery to make a shallow full-circle groove halfway down the body of the cuff (Fig. 2d) . This groove will fixate the suture during cuffing. Two cuffs are required per liver, from a 14 and 16 gauge for the infrahepatic vena cava (IHVC) and portal vein (PV), respectively. Sterilize the cuffs before use. 2| Load the system with 500 ml of 3-OMG loading solution and allow the solution to recirculate.  crItIcal step Ensure that the bubble trap is sufficiently filled and that the tubing is bubble-free.
3|
Set the temperature of the supercooling device to 21 °C and confirm the temperature with the thermocouple.
4|
Open the flow of gas (95% O 2 and 5% CO 2 ) to the oxygenator at 1 liter per minute.
5|
Confirm adequate oxygenation and pH of the solution by drawing a 0.4-ml inflow sample and by running it in a blood gas analysis machine. Adjust the pH by titrating NaHCO 3 to correct acidosis and HCl to correct alkalosis.
rat preparation • tIMInG 4 d 6| Allow the animals to acclimate for a minimum of 3 d in a temperature-controlled room with a 12-h light/dark cycle.  crItIcal step All steps must be outlined in an IACUC-approved animal protocol.
7|
Fast the animal overnight by removing all food in the cage, leaving ad libitum access to water.
rat liver procurement • tIMInG 90-120 min 8| Weigh the rat before beginning the procedure.  crItIcal step Before beginning the surgical procedure, verify that the SNMP system is properly primed (see Steps 1-5).
9|
Restrain the donor in a rat restraint cone and place the opening in the nozzle of the anesthesia system. The anesthesia system should be set to 5% isoflurane with an oxygen flow of 0.8 ml/min for induction.  crItIcal step Monitor anesthesia continuously by assessing the frequency and depth of respiration, and check for a response to tail or toe pinching every 5 min.
10|
Shave the entire abdomen of the animal using a rodent hair clipper. Restrain the animal in a supine position on the sterile surgical table, with its face in the anesthesia system's nozzle on the far side. Scrub the skin with an aqueous iodophor solution to disinfect, and cover the animal with sterile surgical drapes. Lower the anesthesia to 2-3% isoflurane for maintenance.
11|
Lift the skin 5 mm above the xiphoid process, and then make a continuous lateral cut to both sides following the lower border of the rib cage. Retract the abdominal wall to provide good visualization.
12|
Mobilize the liver by cutting the ligaments on all sides of the organ.
13| Identify and ligate the diaphragmatic vein, which drains into the suprahepatic vena cava (SHVC).
14| Elongate the IHVC by ligating the right adrenal vein together with the lumbar venous plexus and the right renal vein.
15|
Identify and ligate the gastroduodenal vein (GDV) and splenic vein. Retracting the duodenum upward exposes the PV. The GDV can be found above the PV, most proximal to the liver. It runs closely alongside the splenic artery, which is to the left and slightly above the GDV. The splenic vein can be better exposed by placing slight traction on the PV using a moist cotton swab.
16|
Ligate and cut the hepatic artery.
17| Cannulate the bile duct using a 6-cm segment of 28-gauge polyethylene tubing, and cut the duct distally.
18| Administer 2,000 U of heparin per kg body weight and wait for 5 min to allow circulation.
19|
Use micro clips to cross-clamp the IHVC between the right and left renal vein and then the PV, providing maximum length to the vein. Make a hemicircumferential cut in the PV. Minimal bleeding will occur from the cut site.
20| Insert the catheterized (18 gauge) syringe of 10-ml 3-OMG loading solution (21 °C), and flush the liver with 5 ml over the course of 20 s (15 ml/min). Retract the liver caudally and cut the diaphragm in a circle around the SHVC.  crItIcal step In parallel to the experimental group, perform Box 1 as a control group.
21|
Cut the ligated diaphragmatic vein above the suture. Cut the SHVC above the diaphragm opening flow from the liver, and continue to flush with the remaining 5 ml of 3-OMG loading solution (21 °C) over the course of 20 s (15 ml/min).
22|
Cut the IHVC below the clamp. To remove the liver, complete the cut through the PV and gently pull the PV upward toward the liver, freeing it from surrounding structures.
23|
Remove the liver and submerge it in 3-OMG loading solution (21 °C) in a sterile container.
24|
Cuff the PV and IHVC with a prefashioned 16 and 14-gauge cuff, respectively. Bring the vessel through the inside of the cuff and wrap it over the top. Secure by tying a suture around the vessel, secured in the cauterized groove.  crItIcal step Ensure that the tail of the cuff would face the back of the animal (dorsally). Proper positioning of the cuff will greatly ease the PV and IHVC anastomosis during transplantation.
25|
Flush the liver through the PV with an additional 10 ml of 3-OMG loading solution (21 °C) over the course of 60 s (10 ml/min), and then weigh the liver. 
28|
Allow drainage of the bile duct cannula into a microcentrifuge tube for quantification and analysis of bile. Ensure that the bile duct is not kinked or in any way obstructing the outflow of bile.
29|
In 1-ml/min increments, increase the flow to 12 ml/min after the system has been closed in the previous step. Ensure that the pressure does not exceed 15 cmH 2 O.
30|
After the first 150 ml of solution has passed through the liver into a waste container, close the tubing and continue recirculation of the remaining 350 ml of solution. Sample (1 ml) the perfusion solution from the organ bowl every 15 min, and store the samples at −80 °C for further analysis.
31|
Sample the perfusion solution from the organ bowl every 15 min and store the samples at −80 °C for further analysis.
32| Take 0.4-ml samples in a 1-ml syringe from both inflow and outflow for blood gas analysis. Inflow samples can be taken from the manometer tube proximal to the PV inflow. Outflow samples can be taken by inserting the syringe with an 18-gauge catheter into the vena cava and by gently drawing a sample. ! cautIon Allow the dead volume in the manometer tube to be renewed to obtain a fresh sample for inflow. While sampling from the vena cava, extreme care must be taken to not injure the endothelium and to avoid the collapse of the venous circulation by drawing too fast.
33|
After 60 min of loading SNMP, lower the temperature on the controlled rate chiller at a rate of 1 °C/min. After 17 min, when the system has been cooled to 4 °C, the liver can be disconnected from the SNMP system. 
36|
Place the liver in a sealable sterile bag filled with 75 ml of supercooling solution. Remove air from the bag before fully sealing it (Fig. 1e) .  crItIcal step Ensure that the bag is waterproof by very gently squeezing the bag and checking for leaks.
37|
Transfer the bag to the controlled-rate chiller, which is still set to 4 °C. Make sure that the bag is fully submerged in the antifreeze solution and that the bag is not in contact with the sides of the device.
38|
Gradually lower the temperature at a rate of 0.1 °C/min. After 100 min, the temperature will reach the supercooling set point of −6 °C. Confirm the temperature inside the chiller with a thermocouple.
39|
Leave the liver in the controlled rat chiller for 72-96 h. Regularly confirm that the temperature inside the chiller remains stable at −6 °C.  pause poInt The liver can be left in long-term supercooling preservation. Attempt to minimally disrupt the liver or the device during this period.
recovery phase of snMp • tIMInG 5 h 40| At the end of the supercooling period, increase the temperature of the supercooling device to 4 °C at a rate of 0.1 °C/min, while the liver remains inside the device.
41|
When the temperature has reached 0 °C, begin preparing the SNMP system similarly to the procedure outlined in Steps 1-5, but by priming the tubing with recovery solution instead of 3-OMG loading solution, and a flow of 3 ml/min. The temperature of the system will assume the settings of the supercooling device.
42|
When the temperature has reached 4 °C, open the supercooling device and remove the sealed bag. Open the bag and weigh the liver. ? trouBlesHootInG 43| Flush the liver with 10 ml of recovery solution (4 °C) at a rate of 3 ml/min.
44|
Connect the liver to the SNMP system. Cover the organ chamber with a section of sterile Parafilm wrap.  crItIcal step Closely monitor the pressure during the first minutes of perfusion to ensure that it does not exceed 5 cmH 2 O at the beginning of perfusion. If the pressure is too high, the flow rate can be reduced.
? trouBlesHootInG 45| Allow drainage of the bile duct cannula into a microcentrifuge tube for quantification and analysis of bile.
46|
Begin increasing the temperature to 21 °C at a rate of 1 °C/min.
47|
Increase the flow by 1 ml/min every 3 min to a maximum of 12 ml/min.  crItIcal step The pressure that is tolerated by the liver greatly depends on the temperature, and it should be controlled by regulating the flow. Figure 3 illustrates the temperature and flow regimen and recommended maximum pressures during the first 30 min of recovery SNMP. If the pressure permits, the flow can be increased to a maximum of 12 ml/min.
48| Repeat Steps 30-32.
49| After 2.5 h of perfusion, begin the recipient hepatectomy, as described in Steps 52-59.
50| After 3 h of perfusion, disconnect from the SNMP system and weigh the liver.
51|
Before implantation, flush the liver with 10 ml of lactated Ringer's solution (4 °C; 10 ml/min). ! cautIon An adequate flush of the liver is required to remove the hyperkalemic supercooling solution from the liver. Insufficient flushing can lead to potassium-induced cardiac arrhythmias on reperfusion.
orthotopic liver transplantation • tIMInG 120-150 min + follow-up period 52| Repeat Steps 7-12. Ensure that the weight of the recipient does not differ by >20% from the weight of the liver donor.  crItIcal step The liver must be transplanted into a weight-matched syngeneic recipient.
53|
Administer 0.05 mg/kg buprenorphine subcutaneously 30 min before beginning the surgery.
54|
Open the skin and muscle layers of the abdomen by making a midline incision from the xiphoid process to the 1 cm before the pubic bone. Cauterize significant sources of bleeding to prevent excessive blood loss. Suspend the sternum cranially and retract the abdominal wall to maximize exposure. ! cautIon Too much tension on the diaphragm can interfere with respiration.
55|
Ligate the diaphragmatic vein, and double-ligate and cut the adrenal vein, lumbar venous plexus and the hepatic artery.
56|
Ligate the bile duct proximal to the liver, and leave one end of the suture long for suspension.
57|
Place a suture around the left and right PV branches, but do not tie.
58|
Administer 10 ml/kg normal saline through the penile vein, and turn the isoflurane flow down to 1%.
59|
Tie off the right PV, clamp the IHVC and finally tie off the left PV branch, by leaving one end of the suture long. This marks the beginning of the anhepatic phase. Start a timer.  crItIcal step This and the following steps require quick, controlled execution. It is recommended that the surgeon take the opportunity to reorganize instruments and materials, to assess the animal and to verify that all surgical steps have been completed before this step. At this point, the donor liver should be completing the recovery phase, and it should be flushed to remove the preservation solution before transplantation.
60|
Clamp the SHVC, including a 5-mm section of diaphragm, using a Satinsky clamp. Fixate the clamp. ! cautIon The clamp cannot be re-positioned. It is essential to ensure that a sufficient segment of diaphragm is included in the clamp all the way around the SHVC.
61|
Cut the SHVC close to the liver. Cut the right and left PV branches and the IHVC with maximum length on the recipient end.
62|
Transfer the flushed donor liver to the liver recess, and perform a sutured anastomosis of the SHVC.  crItIcal step Flush out any bubbles in both the donor and the recipient SHVC before closing the anastomosis.
63|
Use the suture ends of the right and left PV branches to suspend the recipient PV. Make a small cut in the recipient PV, and insert the PV cuff and fixate with a suture. Remove the clamp on the PV and the Satinsky clamp, marking reperfusion and the end of the anhepatic time. Stop the timer.  crItIcal step A short and consistent anhepatic time is required for recipient survival and comparable results between transplantation. Fresh liver transplants can be transplanted with up to 30 min of anhepatic time, whereas the anhepatic time during the transplantation of preserved livers needs to be <20 min.
64| Make a similar cut in the recipient IHVC, and insert and secure the IHVC cuff in a similar manner.
65|
Cut the bile duct cannula to a length of 15 mm. Make a small cut in the recipient bile duct and insert the free end of the cannula, bringing the two ends of the duct together over a stent. Secure the two ends with a tie.
66|
Check the anastomoses for bleeding, and ensure that the vessels are not twisted and that flow is not obstructed. Irrigate the abdomen with warm saline, and close the muscle and skin in two layers. Additional saline can be administered to compensate for blood loss. Temperature is slowly increased in the first 17 min to 21 °C (gray), whereas the flow is increased in parallel to a maximum of 12 ml/min (green). The pressure should not exceed the temperature-dependent maximum (black).
67| Allow the animal to recover under continuous monitoring under a heat lamp, and perform routine health checks as mandated by an approved animal protocol.  crItIcal step Provide adequate analgesia for a minimum of 72 h. A regimen of 0.05% buprenorphine administered subcutaneously every 12 h is recommended.
68|
Monitor the animal for a desired follow-up period. Routine health and liver function tests include inspecting for clinical signs of liver failure (e.g., jaundice and scratching), weight measurements and blood tests.
? trouBlesHootInG Troubleshooting advice can be found in table 1.
• tIMInG 
antIcIpateD results
While the clinical standard for liver preservation secludes the liver in a closed box between procurement and transplantation, supercooling involves a number of steps that allow direct and indirect observation of the liver and liver function. Besides its purpose for loading and recovery of the liver, machine perfusion has the additional benefit of enabling functional testing of the organ before transplantation. Particularly after preservation, the viability of the organ, reflected as perfusion parameters, can be highly valuable in assessing whether a liver is suitable for transplantation. 
real-time perfusion measurements
While running the perfusion, various perfusion parameters can be measured and observed in real time, including flow and pressure and bile production. Vascular resistance can be approximated from the quotient of pressure over flow to reflect the ease of perfusion . Fresh rat livers with minimal preservation injury should exhibit very similar perfusion hydrodynamics.
In our experiments, after 30 min of perfusion and once a flow rate of 10 ml/min has been reached, the resistance remains very stable throughout the remainder of perfusion, and pressures between 7.5 and 10 cmH 2 O are typically observed (resistance 0.75-1.0; Fig. 4a ). Particularly in fresh livers, pressures that exceed the maximum values outlined in Figure 3 are cause for technical troubleshooting. In fresh rat livers, bile production should be seen within 15 min of perfusion, and it will increase over the first hour, after which a steady bile production will be seen. Increasing preservation injury will result in an absolute change in perfusion parameters, as well increased variation between livers of a single group. Typically, an increase in resistance and decrease in bile production will be observed with longer cold ischemic time (Fig. 4a-c) .
transplant survival
Successful long-term survival after transplantation is the primary endpoint of preservation research. The maximum permissible warm and cold ischemic times have been established in various models, after warm ischemia 21 , cold ischemia 20 and a combination thereof 31 . The SCS control group is important, as it represents the clinical standard. By using UW solution as a cold preservation solution in the SCS group, survival is 100% up to 24 h of preservation (Fig. 4d) . When we extend the preservation time to 48 h after transplantation, survival drops to 50%. Further extending the cold preservation time to 72 h yielded no survival in our experience. Successful supercooling can be expected to prolong preservation time markedly. By following this protocol, we were able to transplant supercooled livers with 58% long-term survival after 96 h of preservation, whereas 100% survival was limited to 72 h. Directly after transplantation, recipients of supercooled livers or livers preserved for extended SCS periods (>12 h) will recover less quickly from the surgery, more slowly regaining consciousness and mobility. Moreover, the recipients of 96-h supercooled livers lose weight during the first week after transplantation (Fig. 4e) . Weight should begin to increase as the appetite of the animal returns, but it remains less than control animals. 
